project id: TCGA-BRCA; case submitter id: TCGA-A2-A3XU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.3; age at index: 35; days to birth: -13046; days to death: 912; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1971; year of death: 2008; age at diagnosis: 13046; ajcc pathologic m: M0; ajcc pathologic n: N1mi; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2089; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-A2-A3XU-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 7.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;